Diabetes Care for Breast Cancer Patients
Completed · Not applicable
Conditions studied: Breast Cancer, PreDiabetes, Type 2 Diabetes
In brief
The goal of this study is to find a new way to make diabetes care better for patients with breast cancer and diabetes who are currently receiving cancer treatment. We will have two groups, the researchers will decide who is in which group. One group will be working with a nurse who is trained in diabetes care while the other does not. This will allow the investigators to see if having a trained nurse as part of the care team can help improve the care the patients receive.
Key facts
- Study ID
- NCT05565534
- Run by
- Weill Medical College of Cornell University
- People needed
- 74
- Starts
- 2023-02-28
- Expected to finish
- 2025-10-06
- Last updated by the study team
- 2026-07-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Newly diagnosed invasive cancer
- Plan to receive neo-adjuvant or adjuvant chemotherapy, targeted therapy, hormonal therapy, or radiation at Weill Cornell Medicine (WCM)
- Age 18+ years
- Pre-diabetes OR type 2 diabetes. Treatment with antidiabetic medication OR
- HbA1c greater than or equal to 5.7 OR
- Random glucose greater than or equal to OR
- Fasting blood glucose greater than or equal to 100
You may not qualify if…
- Patients receiving hospice care
- Type 1 diabetes
Where it is running
- NewYork-Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York, United States
- New York-Presbyterian Queens — Flushing, New York, United States
- Weill Cornell Medicine — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.